Blocking interaction of viral gp120 and CD4-expressing T cells by single-stranded DNA aptamers

International Journal of Biochemistry and Cell Biology

Volumn 51, Issue 1, 2014, Pages 10-18

  Zhao, Nianxi ^a   Pei, Sung Nan ^a   Parekh, Parag ^a   Salazar, Eric ^a   Zu, Youli ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

gp120; HIV infection prevention; Hybrid SELEX; Specific blocking; ssDNA CD4 aptamer

Indexed keywords

APTAMER; CELL SURFACE MARKER; GLYCOPROTEIN GP 120; LIPOCORTIN 5; SINGLE STRANDED DNA;

APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CD4+ T LYMPHOCYTE; CELL ASSAY; CELL GROWTH; CELL SURFACE; CONTROLLED STUDY; FLOW CYTOMETRY; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; ANTAGONISTS AND INHIBITORS; BLOOD; CHEMISTRY; COMBINATORIAL CHEMISTRY; DRUG EFFECTS; HIV INFECTIONS; METABOLISM;

APTAMERS, NUCLEOTIDE; CD4-POSITIVE T-LYMPHOCYTES; DNA, SINGLE-STRANDED; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HUMANS; SELEX APTAMER TECHNIQUE;

EID: 84897463196     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2014.03.008     Document Type: Article

References (47)

1. I. Andrieux-Meyer, A. Calmy, P. Cahn, P. Clayden, G. Raguin, and C. Katlama et al. Preferred antiretroviral drugs for the next decade of scale up J Int AIDS Soc 15 2012 17986
2. C. Cabrera, and B. Clotet Mutations resulting in resistance of antiretroviral drugs in HIV-infected patients Med Clin (Barc) 124 2005 618 619 (Pubitemid 40780792)
3. P. Cahn, and M.A. Wainberg Resistance profile of the new nucleoside reverse transcriptase inhibitor apricitabine J Antimicrob Chemother 65 2010 213 217
4. E. Castro, M. Belair, G.P. Rizzardi, P.A. Bart, G. Pantaleo, and C. Graziosi Independent evolution of hypervariable regions of HIV-1 gp120: V4 as a swarm of N-linked glycosylation variants AIDS Res Hum Retroviruses 24 2008 106 113
5. M. Chang, C.S. Yang, and D.M. Huang Aptamer-conjugated DNA icosahedral nanoparticles as a carrier of doxorubicin for cancer therapy ACS Nano 5 2011 6156 6163
6. C. Cheng, Y.H. Chen, K.A. Lennox, M.A. Behlke, and B.L. Davidson In vivo SELEX for Identification of Brain-penetrating Aptamers Mol Ther Nucleic Acids 2 2013 e67
7. D.J. Copon, and R.H. Ward The CD4-gp120 interaction and AIDS pathogenesis Annu Rev Immunol 9 1991 649 678
8. K.A. Davis, B. Abrams, Y. Lin, and S.D. Jayasena Staining of cell surface human CD4 with 2′-F-pyrimidine-containing RNA aptamers for flow cytometry Nucleic Acids Res 26 17 1998 3915 3924 (Pubitemid 28401340)
9. S. Dhalla, and G. Poole Barriers to participation in actual HIV vaccine trials Curr HIV Res 11 April (3) 2013 238 245
10. C.A. Didigu, and R.W. Doms Novel approaches to inhibit HIV entry Viruses 4 2012 309 324
11. S. Fidler, and P. Bock Prophylactic antiretroviral HIV therapy prevents infection in heterosexual men and women Evid Based Med 18 October (5) 2013 184 185
12. A. Flores, and E. Quesada Entry inhibitors directed towards glycoprotein gp120: an overview on a promising target for HIV-1 therapy Curr Med Chem 20 2013 751 771
13. R.M. Gibson, and E.J. Arts Past, present, and future of entry inhibitors as HIV microbicides Curr HIV Res 10 2012 19 26
14. J. Guo, X. Gao, L. Su, H. Xia, G. Gu, and Z. Pang et al. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery Biomaterials 32 2011 8010 8020
15. H. Hatano Immune activation and HIV persistence: considerations for novel therapeutic interventions Curr Opin HIV AIDS 8 May (3) 2013 211 216
16. B.J. Hicke, C. Marion, Y.F. Chang, T. Gould, C.K. Lynott, and D. Parma et al. Tenascin-C aptamers are generated using tumor cells and purified protein J Biol Chem 276 52 2001 45654 48644
17. C.M. Holtz, and L.M. Mansky Variation of HIV-1 mutation spectra among cell types J Virol 87 2013 5296 5299
18. W.T. Horn, M.A. Convery, N.J. Stonehouse, C.J. Adams, L. Liljas, and S.V. Phillips et al. The crystal structure of a high affinity RNA stem-loop complexed with the bacteriophage MS2 capsid: further challenges in the modeling of ligand-RNA interactions RNA 10 11 2004 1776 1782 (Pubitemid 39426377)
19. M. Hu, and K. Zhang The application of aptamers in cancer research: an up-to-date review Future Oncol 9 2013 369 376
20. K.N. Kang, and Y.S. Lee RNA aptamers: a review of recent trends and applications Adv Biochem Eng Biotechnol 131 2013 153 169
21. J. Liu, M. You, Y. Pu, H. Liu, M. Ye, and W. Tan Recent developments in protein and cell-targeted aptamer selection and applications Curr Med Chem 18 2011 4117 4125
22. A.P. Mann, A. Somasunderam, R. Nieves-Alicea, X. Li, A. Hu, and A.K. Sood et al. Identification of thioaptamer ligand against E-selectin: potential application for inflamed vasculature targeting PLoS ONE 5 9 2010 e13050 [p. 1-11]
23. J.A. Moss HIV/AIDS review Radiol Technol 84 2013 247 267 [quiz p. 268-270]
24. L. Meng, L. Yang, X. Zhao, L. Zhang, H. Zhu, and C. Liu et al. Targeted delivery of chemotherapy agents using a liver cancer-specific aptamer PLoS ONE 7 4 2012 e33434
25. X. Ni, M. Castanares, A. Mukherjee, and S.E. Lupold Nucleic acid aptamers: clinical applications and promising new horizons Curr Med Chem 18 2011 4206 4214
26. G. Pasut, and F.M. Veronese PEG conjugates in clinical development or use as anticancer agents: an overview Adv Drug Deliv Rev 61 2009 1177 1188
27. G. Pasut, and F.M. Veronese PEGylation for improving the effectiveness of therapeutic biomolecules Drugs Today (Barc) 45 2009 687 695
28. M. Peeters, A.F. Aghokeng, and E. Delaporte Genetic diversity among human immunodeficiency virus-1 non-B subtypes in viral load and drug resistance assays Clin Microbiol Infect 16 2010 1525 1531
29. M.L. Scanlon, and R.C. Vreeman Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings HIV AIDS (Auckl) 5 2013 1 17
30. K.S. Schmidt, S. Borkowski, J. Kurreck, A.W. Stephens, R. Bald, and M. Hecht et al. Application of locked nucleic acids to improve aptamer in vivo stability and targeting function Nucleic Acids Res 32 2004 5757 5765 (Pubitemid 39619159)
31. K. Sefah, D. Shangguan, X. Xiong, M.B. O'Donoghue, and W. Tan Development of DNA aptamers using Cell-SELEX Nat Protoc 5 2010 1169 1185
32. K.M. Song, S. Lee, and C. Ban Aptamers and their biological applications Sensors (Basel) 12 2012 612 631
33. K.M. Stray, C. Callebaut, B. Glass, L. Tsai, L. Xu, and B. Muller et al. Mutations in multiple domains of Gag drive the emergence of in vitro resistance to the phosphonate-containing HIV-1 protease inhibitor GS-8374 J Virol 87 2013 454 463
34. B. Strehlitz, C. Reinemann, S. Linkorn, and R. Stoltenburg Aptamers for pharmaceuticals and their application in environmental analytics Bioanal Rev 4 2012 1 30
35. P. Sundaram, J. Wower, and M.E. Byrne A nanoscale drug delivery carrier using nucleic acid aptamers for extended release of therapeutic Nanomedicine 8 2012 1143 1151
36. E. Teissier, F. Penin, and E.I. Pecheur Targeting cell entry of enveloped viruses as an antiviral strategy Molecules 16 2010 221 250
37. W.H. Thiel, T. Bair, A.S. Peek, X. Liu, J. Dassie, and K.R. Stockdale et al. Rapid identification of cell-specific, internalizing RNA aptamers with bioinformatics analyses of a cell-based aptamer selection PLoS ONE 7 2012 e43836
38. V. Thiviyanathan, and D.G. Gorenstein Aptamers and the next generation of diagnostic reagents Proteomics Clin Appl 6 2012 563 573
39. S. Tombelli, and M. Mascini Aptamers biosensors for pharmaceutical compounds Comb Chem High Throughput Screen 13 2010 641 649
40. M. Ulrich, K.C. Linda, A. Sheena, C.H. Stephen, and L.R. Ellis The human immunodeficiency virus gp120 binding site on CD4: delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high-resolution CD4 atomic structure J Exp Med 176 1992 507 517
41. M.A. Wainberg, T. Mesplede, and P.K. Quashie The development of novel HIV integrase inhibitors and the problem of drug resistance Curr Opin Virol 2 2012 656 662
42. J. Wang, Y. Yan, T.P.J. Garrett, J. Liu, D.W. Rodgers, and R.L. Garlick et al. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains Nature 348 1990 411 413
43. T. Wang, and J. Ray Aptamer-based molecular imaging Protein Cell 3 2012 739 754
44. P. Zhang, N. Zhao, Z. Zeng, C.C. Chang, and Y. Zu Combination of an aptamer probe to CD4 and antibodies for multicolored cell phenotyping Am J Clin Pathol 134 2010 586 593
45. N. Zhao, J.M. Fogg, L. Zechiedrich, and Y. Zu Transfection of shRNA-encoding Minivector DNA of a few hundred base pairs to regulate gene expression in lymphoma cells Gene Ther 18 March (3) 2011 220 224
46. N. Zhao, H.G. Bagaria, M.S. Wong, and Y. Zu A nanocomplex that is both tumor cell-selective and cancer gene-specific for anaplastic large cell lymphoma J Nanobiotechnol 9 2011 2
47. N. Zhao, J. You, Z. Zeng, C. Li, and Y. Zu An ultra pH-sensitive and aptamer-equipped nanoscale drug-delivery system for selective killing of tumor cells Small 9 October (20) 2013 3477 3484